Finland· FI-REL-REL65
Ubretid
A distigmine product containing distigmine bromide, registered in Finland by Nycomed Austria GmbH. The same ATC class is registered in 7 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Distigmine is registered in 7 of 19 countries.
Countries holding a registration under ATC N07AA03 (distigmine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 3 of them publish a price we can compare per daily dose
Distigmine · ATC N07AA03
7 / 19 countries
- Czechiaprice
- Finlandprice
- Germany
- Japan
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Active substance
- Distigmine bromide
- Manufacturer
- Nycomed Austria GmbH
- Country
- Finland (FI)
- ATC code
- N07AA03
- ATC class
- Distigmine
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Distigmine in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandUbretidDelfarma Sp. z o.o.
- CzechiaUBRETIDCHEPLAPHARM Arzneimittel GmbH, Greifswald
- United KingdomDistigmine bromide 5mg tabletsSpecial Order
- NetherlandsUbretid 5 mg tablettenEuro Registratie Collectief B.V.
- GermanyUbretidCheplapharm Arzneimittel Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Czechia · Ubretid
- Germany · Ubretid
- Netherlands · Ubretid
- Poland · Ubretid
- Slovakia · Ubretid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b1cd78e2-9ecc-4217-9afe-3451f7fb6ab6 GET /v1/drugs/b1cd78e2-9ecc-4217-9afe-3451f7fb6ab6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "5",
"form": "tabletti",
"route": null,
"ddd_unit": "mg",
"strength": "5 mg",
"atc_label": "distigmiini",
"ma_number": "486",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL65",
"authorised_at": "1964-11-11"
}See everything about distigmine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.